alpine-winter-snow
1 May 2012Big PharmaMaria Nilova and Vadim Chagin

A changing landscape: life sciences in Russia

In Russia, IP rights are regulated by the Civil Code of the Russian Federation (CCRF), and also subject to other legal provisions, such as the Law on Protection of Competition, Customs Code, Criminal Code, and others that form the legislative basis for the enforcement of IP rights. The Federal Law on Drug Circulation is often cited in pharmaceutical court cases when establishing the presence or absence of patent and trademark infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
27 November 2025   Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.
Big Pharma
20 November 2025   A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance.
Big Pharma
10 November 2025   According to new research, generic and brand-name pharma companies are ramping up ANDA litigation with Sun Pharma and Bristol Myers Squibb leading the charge.